<SEC-DOCUMENT>0001437749-21-019544.txt : 20210812
<SEC-HEADER>0001437749-21-019544.hdr.sgml : 20210812
<ACCEPTANCE-DATETIME>20210812080949
ACCESSION NUMBER:		0001437749-21-019544
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20210812
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210812
DATE AS OF CHANGE:		20210812

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Moleculin Biotech, Inc.
		CENTRAL INDEX KEY:			0001659617
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				474671999
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37758
		FILM NUMBER:		211165554

	BUSINESS ADDRESS:	
		STREET 1:		5300 MEMORIAL DRIVE
		STREET 2:		SUITE 950
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77007
		BUSINESS PHONE:		713-300-5160

	MAIL ADDRESS:	
		STREET 1:		5300 MEMORIAL DRIVE
		STREET 2:		SUITE 950
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77007
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>mbrx-20210812.htm
<TEXT>
<XBRL>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:naics="http://xbrl.sec.gov/naics/2021" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:utreg="http://www.xbrl.org/2009/utr" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:thunderdome="http://www.RDGFilings.com" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:rr="http://xbrl.sec.gov/rr/2018-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:mbrx="http://www.mbrx.com/20210812"><head>
	<title>mbrx20210730_8k.htm</title>

	<!-- Generated by ThunderDome Portal - 8/12/2021 12:02:09 PM -->
<meta http-equiv="Content-Type" content="text/html" /></head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;"><div style="display: none">
<ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="d20218K" name="dei:AmendmentFlag">false</ix:nonNumeric>
<ix:nonNumeric contextRef="d20218K" name="dei:EntityCentralIndexKey">0001659617</ix:nonNumeric>

</ix:hidden>
<ix:references>
<link:schemaRef xlink:href="mbrx-20210812.xsd" xlink:type="simple" />
</ix:references>
<ix:resources>
<xbrli:context id="d20218K">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001659617</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2021-08-12</xbrli:startDate>
<xbrli:endDate>2021-08-12</xbrli:endDate>
</xbrli:period>
</xbrli:context>


</ix:resources>
</ix:header>
</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 24pt;"><b>UNITED STATES</b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 24pt;"><b>SECURITIES AND EXCHANGE COMMISSION</b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 24pt;"><b>WASHINGTON, D.C. 20549</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 24pt;"><b>FORM <ix:nonNumeric contextRef="d20218K" name="dei:DocumentType"><b><b>8-K</b></b></ix:nonNumeric></b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 24pt;"><b>CURRENT REPORT</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 24pt;"><b>PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 24pt;"><b>DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): <ix:nonNumeric contextRef="d20218K" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate"><b><b>August 12, 2021</b></b></ix:nonNumeric></b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="text-align:center;font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><img alt="mbrx20210730_8kimg001.jpg" src="mbrx20210730_8kimg001.jpg" style="width:227;height:60;" /></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 24pt;"><ix:nonNumeric contextRef="d20218K" name="dei:EntityRegistrantName"><b>MOLECULIN BIOTECH, INC.</b></ix:nonNumeric></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 24pt;">(Exact Name of Registrant as Specified in its Charter)</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:middle;width:4.3%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20218K" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode"><span style="text-transform:uppercase;">delaware</span></ix:nonNumeric></div>
			</td>
			<td style="vertical-align:middle;width:4.4%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20218K" name="dei:EntityFileNumber"><b>001-37758</b></ix:nonNumeric></div>
			</td>
			<td style="vertical-align:middle;width:4.3%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20218K" name="dei:EntityTaxIdentificationNumber"><b>47-4671997</b></ix:nonNumeric></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:4.3%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(State or Other Jurisdiction of Incorporation or Organization)</div>
			</td>
			<td style="vertical-align:top;width:4.4%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Commission File No.)</div>
			</td>
			<td style="vertical-align:top;width:4.3%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(I.R.S. Employer Identification No.)</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 24pt;"><ix:nonNumeric contextRef="d20218K" name="dei:EntityAddressAddressLine1"><b>5300 Memorial Drive</b></ix:nonNumeric><b>, <b>Suite 950</b>, <ix:nonNumeric contextRef="d20218K" name="dei:EntityAddressCityOrTown"><b><b>Houston</b></b></ix:nonNumeric>, <ix:nonNumeric contextRef="d20218K" name="dei:EntityAddressStateOrProvince"><b><b>TX</b></b></ix:nonNumeric> <ix:nonNumeric contextRef="d20218K" name="dei:EntityAddressPostalZipCode"><b><b>77007</b></b></ix:nonNumeric></b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 24pt;">(Address of principal executive offices and zip code)</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 24pt;"><b>(<ix:nonNumeric contextRef="d20218K" name="dei:CityAreaCode"><b><b>713</b></b></ix:nonNumeric>) <ix:nonNumeric contextRef="d20218K" name="dei:LocalPhoneNumber"><b><b>300-5160</b></b></ix:nonNumeric></b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 24pt;">(Registrant&#8217;s telephone number, including area code)</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 24pt;">(Former name or former address, if changed from last report)</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 24pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<i>see </i>General Instruction A.2. below):</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:bottom;width:13%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><ix:nonNumeric contextRef="d20218K" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric> Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:13%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><ix:nonNumeric contextRef="d20218K" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric> Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:13%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><ix:nonNumeric contextRef="d20218K" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric> Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:13%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><ix:nonNumeric contextRef="d20218K" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric> Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-14(c)).</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 24pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).&#xa0; Emerging growth company <ix:nonNumeric contextRef="d20218K" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 24pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <ix:nonNumeric contextRef="d20218K" format="ixt-sec:boolballotbox" name="dei:EntityExTransitionPeriod">&#9746;</ix:nonNumeric></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 24pt;">Securities registered pursuant to Section 12(b) of the Act:</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:4.6%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Title of each class</b></div>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:3.9%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Trading Symbol (s)</b></div>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:4.6%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Name of each exchange on which registered</b></div>
			</td>
		</tr>
		<tr>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:4.6%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20218K" name="dei:Security12bTitle">Common Stock</ix:nonNumeric>, par value $.001 per share</div>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:3.9%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20218K" name="dei:TradingSymbol">MBRX</ix:nonNumeric></div>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:4.6%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">The <ix:nonNumeric contextRef="d20218K" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">NASDAQ</ix:nonNumeric> Stock Market LLC</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#xa0;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">&#xa0;</div>
</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>Item 2.02</b>&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;<b>Results of Operations and Financial Condition.</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 16pt;text-indent:36pt;">On August 12, 2021, Moleculin Biotech, Inc. (the &#8220;Company&#8221;) issued a press release announcing its financial results for the quarter ended June 30, 2021&#xa0;and recent operational highlights. A copy of the press release is attached to this report as Exhibit 99.1 and is incorporated by reference herein.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 16pt;"><b>Item 9.01 </b>&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;<b>Financial Statements and Exhibits.</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 16pt;">(d)&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;Exhibits.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:3.3%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Exhibit No. </b></div>
			</td>
			<td style="vertical-align:top;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Description</b></div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:3.3%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="ex_269919.htm" style="-sec-extract:exhibit;">99.1</a></div>
			</td>
			<td style="vertical-align:top;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="ex_269919.htm" style="-sec-extract:exhibit;">Press Release dated August 12, 2021</a></div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:3.3%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">104</div>
			</td>
			<td style="vertical-align:top;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Cover page Interactive Data File (embedded within the Inline XBRL document)</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 24pt;"><b><span style="text-decoration: underline;">SIGNATURE</span></b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 16pt;text-indent:36pt;">Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:middle;width:6.5%;">&#xa0;</td>
			<td style="vertical-align:middle;width:6.5%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>MOLECULIN BIOTECH, INC.</b></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:6.5%;">&#xa0;</td>
			<td style="vertical-align:middle;width:6.5%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:6.5%;">&#xa0;</td>
			<td style="vertical-align:middle;width:6.5%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:6.5%;">&#xa0;</td>
			<td style="vertical-align:middle;width:6.5%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Date: August 12, 2021</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:6.5%;">&#xa0;</td>
			<td style="vertical-align:middle;width:6.5%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:6.5%;">&#xa0;</td>
			<td style="vertical-align:middle;width:6.5%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">By: <span style="text-decoration: underline;">/s/ Jonathan P. Foster</span></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:6.5%;">&#xa0;</td>
			<td style="vertical-align:middle;width:6.5%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Jonathan P. Foster</div>

			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Chief Financial Officer</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 24pt;">2</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&#xa0;</div>
</div>
</div>
</div>


</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex_269919.htm
<TEXT>
<html><head>
	<title>ex_269919.htm</title>
	<!-- Generated by ThunderDome Portal - 8/10/2021 4:55:42 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;">
<div style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: right;"><b>Exhibit 99.1</b></div>

<div style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><img alt="moleculinlogoresizedclear.jpg" src="moleculinlogoresizedclear.jpg"></div>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:12pt;font-variant:normal;text-align:center;margin:0pt;"><b>Moleculin Reports Second Quarter 2021 Financial Results and Provides Programs Update</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i>- Continued execution of multiple ongoing clinical studies</i> <i>for the treatment of highly resistant tumors and viruses -</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i>- Key clinical and regulatory milestones throughout next 18 months including</i> <i>topline results from the ongoing Phase 1/2 study of Annamycin for treatment of AML and interim data from U.S. Phase 1b/2 study of Annamycin for the treatment of soft tissue sarcoma (STS) lung metastases -</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>HOUSTON, Augus<font style="background-color:#ffffff;">t 12, </font>2021 /PRNewswire/ -- Moleculin Biotech, Inc.</b>, (Nasdaq: MBRX) (Moleculin or the Company), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses, today announced its financial results for the quarter ended June 30, 2021. The Company also provided an update on its portfolio of oncology drug candidates for the treatment of highly resistant tumors and viruses.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#8220;I am pleased with the progress made over the course of the past quarter, of particular note, in the clinical development program for Annamycin, our next-generation anthracycline. We are committed to&nbsp;advancing our three core technologies to meet the needs in a number of oncology and viral indications. We believe the next 18 months hold a number of key inflection points and value drivers for the Company. We believe Moleculin is well-positioned to continue building momentum and drive shareholder value in the near- and long-term," commented Walter Klemp, Chairman and CEO of Moleculin.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Recent Highlights </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:14pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Received approval to extend dose escalation in Phase 1/2 European clinical trial evaluating Annamycin for the treatment of acute myeloid leukemia (AML).</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:14pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Commenced enrollment and dosed the first subject in its U.S. Phase 1b/2 clinical trial evaluating Annamycin for the treatment of soft tissue sarcoma (STS) lung metastases.</p>
			</td>
		</tr>
		<tr>
			<td style="width:14pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">&#9679;</td>
			<td style="vertical-align:top;">Held further meetings with the MHRA in the UK regarding a healthy volunteer trial with WP1122 for the treatment of COVID-19.&nbsp;</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Programs Update </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Next Generation Anthracycline - Annamycin</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Annamycin,&nbsp;the Company&#8217;s next-generation anthracycline was designed to be noncardiotoxic (unlike all currently approved anthracyclines) and&nbsp;has demonstrated its&nbsp;lack of cardiotoxicity in recently conducted human clinical trials for the treatment of AML. The Company believes that, because of this unique improvement in safety, the use of Annamycin may not face the same usage limitations imposed on doxorubicin. Additionally, Annamycin has been shown in animal models to accumulate in the lungs at up to 30-fold the level of doxorubicin.&nbsp;Annamycin is currently in development for the treatment of AML and STS lung metastases.&nbsp;For more information about the Phase 1b/2 study evaluating Annamycin for the treatment of STS lung metastases, please visit clinicaltrials.gov and reference identifier NCT04887298.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Upcoming Milestones Expectations</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:18pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="background-color:#ffffff;">H2 2021: R</font>eport cohort topline results from the ongoing Phase 1/2 study for treatment of AML and report the study's topline results.</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:18pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="background-color:#ffffff;">H2 2021: C</font>ommence Phase 1/2 study in Europe for the treatment of AML evaluating combination therapy of Annamycin + AraC.</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:18pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">H2 2021: Commencement of an investigator-funded, second Phase 1b/2 clinical trial of Annamycin in sarcoma lung metastases in Europe</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>First-in-class p-STAT3 inhibitors - WP1066 and WP1220</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">WP1066 is one of several Immune/Transcription Modulators, designed to stimulate the immune response to tumors by inhibiting the errant activity of Regulatory T-Cells (TRegs) while also inhibiting key oncogenic transcription factors, including p-STAT3 (phosphorylated signal transducer and activator of transcription 3), c-Myc (a cellular signal transducer named after a homologous avian virus called Myelocytomatosis) and HIF-1&#945; (hypoxia inducible factor 1&#945;). These transcription factors are widely sought targets that are believed to contribute to an increase in cell survival and proliferation, and the angiogenesis (coopting vasculature for blood supply), invasion, metastasis and inflammation associated with tumors. They may also play a role in the inability of immune checkpoint inhibitors to affect more resistant tumors. WP1220 is a close analog to WP1066 that the Company has developed as a potential topical therapy for skin-related diseases.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">WP1220 was evaluated for the treatment of Cutaneous T-Cell Lymphoma (CTCL) and, based on those results, we are seeking collaborators for future development. WP1066 is currently being evaluated for the treatment of pediatric brain tumors, including Diffuse Interstitial Pontine Glioma (DIPG). Additionally, WP1066 + radiation is being evaluated, pre-clinically,&nbsp;in the treatment&nbsp;of Glioblastoma Multiforme (GBM).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Upcoming Milestones Expectations</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:18pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">&#9679;</td>
			<td style="vertical-align:top;">H2 2021: File a US Investigative New Drug application (IND) for the treatment of certain adult cancer(s) with WP1066 and identify an institution to commence an associated investigator-funded Phase 1a/1B study.</td>
		</tr>
		<tr>
			<td style="width:18pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">&#9679;</td>
			<td style="vertical-align:top;">H2 2021: Continue support of the physician-sponsored pediatric brain tumor clinical trial</td>
		</tr>
		<tr>
			<td style="width:18pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">H1 2022: Facilitate&nbsp;launch of physician-sponsored Phase 2 study of WP1066 for the treatment of pediatric brain tumors including DIPG.</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:18pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Actively seek&nbsp;collaboration with a strategic partner in the near term for external funding for the continued development of WP1220 in a Phase 2 clinical trial as a topical therapy for CTCL.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Infectious Disease and Metabolism/Glycosylation Inhibitors- WP1122, WP1096 and WP1097 Portfolio</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Moleculin has new compounds designed to target the roles of glycolysis and glycosylation in both cancer and viral diseases. The Company&#8217;s lead Metabolism/Glycosylation Inhibitor, WP1122, is a prodrug of 2-DG that appears to improve the drug-like properties of 2-DG by increasing its circulation time and improving tissue/organ distribution.&nbsp;Recent published research has identified that 2-DG has antiviral potential against SARS-CoV-2 <i>in vitro</i> and, based on publicly available information, a recently completed Phase 2 clinical trial by an unrelated company in India has reported&nbsp;efficacy in COVID-19 patients, resulting in the Emergency Use Authorization of 2-DG by the Drugs Controller General of India. Moleculin believes WP1122 has the potential&nbsp;to become an important drug to potentiate existing therapies, including checkpoint inhibitors. The Company recently engaged in discussions with the Medicines and Healthcare Products Regulatory Agency (MHRA) in the United Kingdom (UK) regarding the potential for beginning clinical trials of WP1122 without the need for additional preclinical animal efficacy models. Based on their initial discussions with the MHRA, the Company believes that a COVID-19 animal model will not be required in order to submit a clinical trial application (CTA) for a Phase 1 clinical trial beginning with healthy volunteers in that country, although no final determination has been made by the MHRA. During the second quarter these discussions continued. Additionally, the Company is in the process of identifying countries where potential future Phase 2 clinical studies could occur. The Company is also engaged in preclinical development of additional antimetabolites (WP1096 and WP1097) targeting glycolysis and glycosylation.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Upcoming Milestones Expectations</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:18pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="background-color:#ffffff;">H2 2021: Seek to initiate Phase 1a/1b study of WP1122 for the treatment of COVID-19 in the UK.</font></p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:18pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><font style="background-color:#ffffff;">&#9679;</font></p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="background-color:#ffffff;">H2 2021: Potential to launch Phase 2 pivotal study of WP1122 for the treatment of COVID-19 outside the U.S.</font></p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:18pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><font style="background-color:#ffffff;">&#9679;</font></p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="background-color:#ffffff;">H2 2021: F</font>ile an IND in the U.S. for the treatment of certain cancers such as GBM and pancreatic cancer, with WP1122.</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:18pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Ongoing preclinical development work in anti-viral indications such as HIV, Zika, and Dengue. IND targeted for 2022.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Summary of Financial Results for Second Quarter 2021</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Research and development (R&amp;D) expense was $3.0 million and $3.3 million for the three months ended June 30, 2021 and 2020, respectively. The decrease of $0.3 million is mainly related to the timing of costs incurred in 2020 of producing additional drug product for Annamycin clinical trials.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">General and administrative expense was $2.4 million and $1.7 million for the three months ended June 30, 2021 and 2020, respectively. The increase of $0.7 million is mainly related to an increase in consulting and advisory fees and an increase in the Company&#8217;s corporate insurance.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">For the six months ended June 30, 2021 and 2020, the Company incurred net losses of $8.7 million and $11.3 million, respectively, and had net cash flows used in operating activities of $10.4 million and $9.3 million, respectively.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Company ended the quarter with approximately $79.5 million of cash. The Company believes that this cash is sufficient to meet its projected operating requirements, which include a forecasted increase over its current R&amp;D rate of expenditures, into&nbsp;2024.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>About Moleculin Biotech, Inc.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Moleculin Biotech, Inc. is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of highly resistant tumors and viruses. The Company&#8217;s lead program, Annamycin is a next-generation anthracycline designed to be noncardiotoxic and to avoid multidrug resistance mechanisms. In addition, Annamycin has been shown in animal models to reach higher concentration levels than doxorubicin (a leading anthracycline) in certain key organs, such as the lungs, liver and pancreas considered to be difficult-to-reach &#8220;sanctuary sites&#8221; for tumors. Annamycin is currently in development for the treatment of relapsed or refractory acute myeloid leukemia (AML) and soft tissue sarcoma (STS) lung metastases.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Additionally, the Company is developing WP1066, an Immune/Transcription Modulator capable of inhibiting p-STAT3 and other oncogenic transcription factors while also stimulating a natural immune response, targeting brain tumors, pancreatic and other cancers, and WP1220, an analog to WP1066, for the topical treatment of cutaneous T-cell lymphoma. Moleculin is also engaged in the development of a portfolio of antimetabolites, including WP1122 for the potential treatment of COVID-19 and other viruses, as well as cancer indications including brain tumors, pancreatic and other cancers.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">For more information about the Company, please visit www.moleculin.com and connect on Twitter, LinkedIn and Facebook.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Forward-Looking Statements</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><br>
Some of the statements in this release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995, which involve risks and uncertainties. Forward-looking statements in this press release include, without limitation, the ability of Moleculin to meet each of the milestones set forth above on the timeline estimated, if at all. Although Moleculin believes that the expectations reflected in such forward-looking statements are reasonable as of the date made, expectations may prove to have been materially different from the results expressed or implied by such forward-looking statements. Moleculin has attempted to identify forward-looking statements by terminology including ''believes,'' ''estimates,'' ''anticipates,'' ''expects,'' ''plans,'' ''projects,'' ''intends,'' ''potential,'' ''may,'' ''could,'' ''might,'' ''will,'' ''should,'' ''approximately'' or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors, including those discussed under Item 1A. "Risk Factors" in our most recently filed Form 10-K filed with the Securities and Exchange Commission ("SEC") and updated from time to time in our Form 10-Q filings and in our other public filings with the SEC. Any forward-looking statements contained in this release speak only as of its date. We undertake no obligation to update any forward-looking statements contained in this release to reflect events or circumstances occurring after its date or to reflect the occurrence of unanticipated events.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Investor Contact:</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="margin: 0pt;">JTC Team, LLC</p>

<p style="margin: 0pt;">Jenene Thomas</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(833) 475-8247</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">MBRX@jtcir.com</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 24pt;"><b>-- Financial Tables Follow--</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 1011px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Moleculin Biotech, Inc.</b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 5px;">&nbsp;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 7px;">&nbsp;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 173px;">&nbsp;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 2px;">&nbsp;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 6px;">&nbsp;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 12px;">&nbsp;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 187px;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 3px;">&nbsp;</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 1011px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Unaudited Condensed Consolidated Balance Sheets</b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 5px;">&nbsp;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 7px;">&nbsp;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 173px;">&nbsp;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 2px;">&nbsp;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 6px;">&nbsp;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 12px;">&nbsp;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 187px;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 3px;">&nbsp;</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 1011px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>(in thousands)</b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 5px;">&nbsp;</td>
			<td colspan="2" style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 182px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>June 30, 2021</b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 2px;">&nbsp;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 6px;">&nbsp;</td>
			<td colspan="2" style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 201px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>December 31, 2020</b></p>
			</td>
			<td style="vertical-align: bottom; width: 3px;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 1011px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Current assets:</p>
			</td>
			<td style="vertical-align: bottom; width: 5px;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 7px;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 173px;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 2px;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 6px;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 12px;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 187px;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 3px;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: bottom; width: 1011px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Cash and cash equivalents</p>
			</td>
			<td style="vertical-align: bottom; width: 5px;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 7px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">$</p>
			</td>
			<td style="vertical-align: bottom; width: 173px; text-align: right;">79,506</td>
			<td style="vertical-align: bottom; width: 2px;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 6px;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 12px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">$</p>
			</td>
			<td style="vertical-align: bottom; width: 187px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">15,173</p>
			</td>
			<td style="vertical-align: bottom; width: 3px;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 1011px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Prepaid expenses and other current assets</p>
			</td>
			<td style="vertical-align: bottom; width: 5px;">&nbsp;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 7px;">&nbsp;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 173px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">2,330</p>
			</td>
			<td style="vertical-align: bottom; width: 2px;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 6px;">&nbsp;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 12px;">&nbsp;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 187px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">2,025</p>
			</td>
			<td style="vertical-align: bottom; width: 3px;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: bottom; width: 1011px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Total current assets</p>
			</td>
			<td style="vertical-align: bottom; width: 5px;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 7px;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 173px; text-align: right;">81,836</td>
			<td style="vertical-align: bottom; width: 2px;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 6px;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 12px;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 187px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">17,198</p>
			</td>
			<td style="vertical-align: bottom; width: 3px;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 1011px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Furniture and equipment, net</p>
			</td>
			<td style="vertical-align: bottom; width: 5px;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 7px;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 173px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">395</p>
			</td>
			<td style="vertical-align: bottom; width: 2px;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 6px;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 12px;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 187px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">483</p>
			</td>
			<td style="vertical-align: bottom; width: 3px;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: bottom; width: 1011px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Intangible assets</p>
			</td>
			<td style="vertical-align: bottom; width: 5px;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 7px;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 173px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">11,148</p>
			</td>
			<td style="vertical-align: bottom; width: 2px;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 6px;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 12px;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 187px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">11,148</p>
			</td>
			<td style="vertical-align: bottom; width: 3px;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 1011px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Operating lease right-of-use asset</p>
			</td>
			<td style="vertical-align: bottom; width: 5px;">&nbsp;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 7px;">&nbsp;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 173px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">155</p>
			</td>
			<td style="vertical-align: bottom; width: 2px;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 6px;">&nbsp;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 12px;">&nbsp;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 187px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">202</p>
			</td>
			<td style="vertical-align: bottom; width: 3px;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: bottom; width: 1011px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Total assets</p>
			</td>
			<td style="vertical-align: bottom; width: 5px;">&nbsp;</td>
			<td style="border-bottom: 3px double rgb(0, 0, 0); vertical-align: bottom; width: 7px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">$</p>
			</td>
			<td style="border-bottom: 3px double rgb(0, 0, 0); vertical-align: bottom; width: 173px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">93,534</p>
			</td>
			<td style="vertical-align: bottom; width: 2px;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 6px;">&nbsp;</td>
			<td style="border-bottom: 3px double rgb(0, 0, 0); vertical-align: bottom; width: 12px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">$</p>
			</td>
			<td style="border-bottom: 3px double rgb(0, 0, 0); vertical-align: bottom; width: 187px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">29,031</p>
			</td>
			<td style="vertical-align: bottom; width: 3px;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 1011px;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 5px;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 7px;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 173px;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 2px;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 6px;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 12px;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 187px;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 3px;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: bottom; width: 1011px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Current liabilities:</p>
			</td>
			<td style="vertical-align: bottom; width: 5px;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 7px;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 173px;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 2px;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 6px;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 12px;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 187px;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 3px;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 1011px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Accounts payable and accrued expenses and other current liabilities</p>
			</td>
			<td style="vertical-align: bottom; width: 5px;">&nbsp;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 7px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">$</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 173px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">3,350</p>
			</td>
			<td style="vertical-align: bottom; width: 2px;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 6px;">&nbsp;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 12px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">$</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 187px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">2,920</p>
			</td>
			<td style="vertical-align: bottom; width: 3px;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: bottom; width: 1011px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Total current liabilities</p>
			</td>
			<td style="vertical-align: bottom; width: 5px;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 7px;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 173px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">3,350</p>
			</td>
			<td style="vertical-align: bottom; width: 2px;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 6px;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 12px;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 187px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">2,920</p>
			</td>
			<td style="vertical-align: bottom; width: 3px;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 1011px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Operating lease liability - long-term, net of current portion</p>
			</td>
			<td style="vertical-align: bottom; width: 5px;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 7px;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 173px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">94</p>
			</td>
			<td style="vertical-align: bottom; width: 2px;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 6px;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 12px;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 187px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">159</p>
			</td>
			<td style="vertical-align: bottom; width: 3px;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: bottom; width: 1011px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Warrant liability - long term</p>
			</td>
			<td style="vertical-align: bottom; width: 5px;">&nbsp;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 7px;">&nbsp;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 173px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">5,390</p>
			</td>
			<td style="vertical-align: bottom; width: 2px;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 6px;">&nbsp;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 12px;">&nbsp;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 187px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">8,192</p>
			</td>
			<td style="vertical-align: bottom; width: 3px;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 1011px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Total liabilities</p>
			</td>
			<td style="vertical-align: bottom; width: 5px;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 7px;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 173px; text-align: right;">8,834</td>
			<td style="vertical-align: bottom; width: 2px;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 6px;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 12px;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 187px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">11,271</p>
			</td>
			<td style="vertical-align: bottom; width: 3px;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: bottom; width: 1011px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Total stockholders' equity</p>
			</td>
			<td style="vertical-align: bottom; width: 5px;">&nbsp;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 7px;">&nbsp;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 173px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">84,700</p>
			</td>
			<td style="vertical-align: bottom; width: 2px;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 6px;">&nbsp;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 12px;">&nbsp;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 187px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">17,760</p>
			</td>
			<td style="vertical-align: bottom; width: 3px;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 1011px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Total liabilities and stockholders' equity</p>
			</td>
			<td style="vertical-align: bottom; width: 5px;">&nbsp;</td>
			<td style="border-bottom: 3px double rgb(0, 0, 0); vertical-align: bottom; width: 7px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">$</p>
			</td>
			<td style="border-bottom: 3px double rgb(0, 0, 0); vertical-align: bottom; width: 173px; text-align: right;">93,534</td>
			<td style="vertical-align: bottom; width: 2px;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 6px;">&nbsp;</td>
			<td style="border-bottom: 3px double rgb(0, 0, 0); vertical-align: bottom; width: 12px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">$</p>
			</td>
			<td style="border-bottom: 3px double rgb(0, 0, 0); vertical-align: bottom; width: 187px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">29,031</p>
			</td>
			<td style="vertical-align: bottom; width: 3px;">&nbsp;</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Unaudited Condensed Consolidated Statements of Operations</b></p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td colspan="6" style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Three Months Ended June 30,</b></p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td colspan="6" style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Six Months Ended June, 30</b></p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>(in thousands, except share and per share amounts)</b></p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2021</b></p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2020</b></p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2021</b></p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2020</b></p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Revenues</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">$</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">&#8212;</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">$</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">&#8212;</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">$</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">&#8212;</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">$</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">&#8212;</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Operating expenses:</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Research and development</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">3,039</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">3,329</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">7,145</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">6,535</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">General and administrative and depreciation</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">2,478</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">1,705</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">4,461</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">3,561</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Total operating expenses</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">5,517</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">5,034</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">11,606</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">10,096</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Loss from operations</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">(5,517</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">(5,034</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">(11,606</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">(10,096</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Other income (loss):</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Gain (loss) from change in fair value of warrant liability</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">1,173</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">(5,099</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">)</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">2,750</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">(1,254</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">)</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Other income, net</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">8</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">17</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">18</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">22</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Interest income, net</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">92</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">4</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">149</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">7</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Net loss</p>
			</td>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
			<td style="border-bottom:double 3px #000000;vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">$</p>
			</td>
			<td style="border-bottom:double 3px #000000;vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">(4,244</p>
			</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p>
			</td>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
			<td style="border-bottom:double 3px #000000;vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">$</p>
			</td>
			<td style="border-bottom:double 3px #000000;vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">(10,112</p>
			</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p>
			</td>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
			<td style="border-bottom:double 3px #000000;vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">$</p>
			</td>
			<td style="border-bottom:double 3px #000000;vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">(8,689</p>
			</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p>
			</td>
			<td style="vertical-align:middle;width:auto;">&nbsp;</td>
			<td style="border-bottom:double 3px #000000;vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">$</p>
			</td>
			<td style="border-bottom:double 3px #000000;vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">(11,321</p>
			</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Net loss per common share - basic and diluted</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="border-bottom:double 3px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">$</p>
			</td>
			<td style="border-bottom:double 3px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">(0.15</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="border-bottom:double 3px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">$</p>
			</td>
			<td style="border-bottom:double 3px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">(1.02</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="border-bottom:double 3px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">$</p>
			</td>
			<td style="border-bottom:double 3px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">(0.35</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="border-bottom:double 3px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">$</p>
			</td>
			<td style="border-bottom:double 3px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">(1.24</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Weighted average common shares outstanding - basic and diluted</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="border-bottom:double 3px #000000;vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="border-bottom:double 3px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">28,451,532</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="border-bottom:double 3px #000000;vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="border-bottom:double 3px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">9,913,878</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="border-bottom:double 3px #000000;vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="border-bottom:double 3px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">25,148,399</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="border-bottom:double 3px #000000;vertical-align:bottom;width:auto;">&nbsp;</td>
			<td style="border-bottom:double 3px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">9,117,856</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&nbsp;</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p>&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>mbrx-20210812.xsd
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 8/12/2021 12:02:10 PM-->
<xsd:schema xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:mbrx="http://www.mbrx.com/20210812" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.mbrx.com/20210812">
<xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
<xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
<xsd:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/stpr/2021" schemaLocation="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd"/>
<xsd:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
<xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/sic/2021" schemaLocation="https://xbrl.sec.gov/sic/2021/sic-2021.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/currency/2021" schemaLocation="https://xbrl.sec.gov/currency/2021/currency-2021.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/exch/2021" schemaLocation="https://xbrl.sec.gov/exch/2021/exch-2021.xsd"/>

<xsd:annotation>
<xsd:appinfo>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mbrx-20210812_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mbrx-20210812_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mbrx-20210812_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
<link:roleType id="statement-document-and-entity-information" roleURI="http://www.mbrx.com/20210812/role/statement-document-and-entity-information">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase">000 - Document - Document And Entity Information</link:definition>
<link:usedOn>link:calculationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:presentationLink</link:usedOn>
</link:roleType>
</xsd:appinfo>
</xsd:annotation>
<xsd:element abstract="true" id="mbrx_DocumentAndEntityInformation" name="DocumentAndEntityInformation" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>mbrx-20210812_def.xml
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 8/12/2021 12:02:10 PM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"/>
<link:roleRef roleURI="http://www.mbrx.com/20210812/role/statement-document-and-entity-information" xlink:href="mbrx-20210812.xsd#statement-document-and-entity-information" xlink:type="simple"/>
<link:definitionLink xlink:role="http://www.mbrx.com/20210812/role/statement-document-and-entity-information" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>

<link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>


<link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
<link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
<link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
<link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
<link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" xlink:type="arc"/>
<link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" xlink:type="arc"/>
<link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" xlink:type="arc"/>
<link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" xlink:type="arc"/>
<link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" xlink:type="arc"/>
<link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" xlink:type="arc"/>
<link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" xlink:type="arc"/>
<link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" xlink:type="arc"/>
<link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" xlink:type="arc"/>
<link:definitionArc order="14" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" xlink:type="arc"/>
<link:definitionArc order="15" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" xlink:type="arc"/>
<link:definitionArc order="16" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:type="arc"/>
<link:definitionArc order="17" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
<link:definitionArc order="18" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityExTransitionPeriod" xlink:type="arc"/>
<link:definitionArc order="19" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" xlink:type="arc"/>
<link:definitionArc order="20" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" xlink:type="arc"/>
<link:definitionArc order="21" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" xlink:type="arc"/>
<link:definitionArc order="22" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
<link:definitionArc order="23" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>

</link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>mbrx-20210812_lab.xml
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 8/12/2021 12:02:10 PM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple"/>
<link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:label xlink:label="dei_EntityDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityDomain" xlink:to="dei_EntityDomain-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:label xlink:label="dei_LegalEntityAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentInformationLineItems-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationLineItems-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentInformationTable-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationTable-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentType-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document, Type</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentPeriodEndDate-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document, Period End Date</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:label xlink:label="dei_EntityRegistrantName-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Registrant Name</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:label xlink:label="dei_EntityIncorporationStateCountryCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Incorporation, State or Country Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:label xlink:label="dei_EntityFileNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, File Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:label xlink:label="dei_EntityTaxIdentificationNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Tax Identification Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressAddressLine1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, Address Line One</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressCityOrTown-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, City or Town</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressStateOrProvince-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, State or Province</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressPostalZipCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, Postal Zip Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:label xlink:label="dei_CityAreaCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:label xlink:label="dei_LocalPhoneNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:label xlink:label="dei_WrittenCommunications-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:label xlink:label="dei_SolicitingMaterial-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:label xlink:label="dei_PreCommencementTenderOffer-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:label xlink:label="dei_PreCommencementIssuerTenderOffer-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:label xlink:label="dei_EntityEmergingGrowthCompany-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Emerging Growth Company</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" xlink:type="locator"/>
<link:label xlink:label="dei_EntityExTransitionPeriod-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Ex Transition Period</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:label xlink:label="dei_Security12bTitle-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:label xlink:label="dei_TradingSymbol-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:label xlink:label="dei_SecurityExchangeName-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:label xlink:label="dei_AmendmentFlag-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:label xlink:label="dei_EntityCentralIndexKey-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Central Index Key</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey-label" xlink:type="arc"/>

</link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>mbrx-20210812_pre.xml
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 8/12/2021 12:02:10 PM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://www.mbrx.com/20210812/role/statement-document-and-entity-information" xlink:href="mbrx-20210812.xsd#statement-document-and-entity-information" xlink:type="simple"/>
<link:presentationLink xlink:role="http://www.mbrx.com/20210812/role/statement-document-and-entity-information" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>

<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>

<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" xlink:type="arc"/>
<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" xlink:type="arc"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" xlink:type="arc"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" xlink:type="arc"/>
<link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" xlink:type="arc"/>
<link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" xlink:type="arc"/>
<link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" xlink:type="arc"/>
<link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" xlink:type="arc"/>
<link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" xlink:type="arc"/>
<link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" xlink:type="arc"/>
<link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" xlink:type="arc"/>
<link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" xlink:type="arc"/>
<link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:type="arc"/>
<link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
<link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityExTransitionPeriod" xlink:type="arc"/>
<link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" xlink:type="arc"/>
<link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" xlink:type="arc"/>
<link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" xlink:type="arc"/>
<link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
<link:presentationArc order="22" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>

</link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>mbrx20210730_8kimg001.jpg
<TEXT>
begin 644 mbrx20210730_8kimg001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  \ .,# 2(  A$! Q$!_\0
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M.'7)4]HM8HQJUWST^1Z29[A17$^(OB/8Z-?MI]I:R7]XC;'"-M56_NYP23[
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M\I-='M5&='M:S_ P5*4H5M-;W7WG#^)[E?&7C[3=.MVWVVV./@]F'F2'_OG
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M1117,=(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
'%%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>moleculinlogoresizedclear.jpg
<TEXT>
begin 644 moleculinlogoresizedclear.jpg
M_]C_X  02D9)1@ ! 0  2 !(  #_X0"L17AI9@  34T *@    @ !0$2  ,
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M>'!A8VME="!E;F0](G<B/SX _^T .%!H;W1O<VAO<" S+C  .$))300$
M    .$))300E       0U!V,V8\ L@3I@ F8[/A"?O_  !$( #P XP,!$0 "
M$0$#$0'_Q  ?   !!0$! 0$! 0           0(#! 4&!P@)"@O_Q "U$  "
M 0,# @0#!04$!    7T! @, !!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1
M\"0S8G*""0H6%Q@9&B4F)R@I*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E
M9F=H:6IS='5V=WAY>H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:W
MN+FZPL/$Q<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ?
M 0 # 0$! 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$
M!  ! G<  0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0T
MX27Q%Q@9&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%
MQL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_VP!#  $! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$" @(" @(" @("
M @,# P,# P,# P/_VP!# 0$! 0$! 0(! 0(" @$" @,# P,# P,# P,# P,#
M P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P/_W0 $ !W_V@ ,
M P$  A$#$0 _ /[^* "@#XY_:H_;U_9?_8WL+=_C9\1[33O$NHVSW>A_#GPY
M:S^*?B1KUNG'VJP\(Z5YE]::86!7[??&ST]&&&G%??\ !/ACQIX@591X;P<J
MF$@TIUYM4L/3;Z2JSM%R[0CS5'TBSXCC'Q&X/X#H*KQ+C(4:TTW"E%.I6G9-
MODI04IM63]YI05M9(_"WXE?\')"IJ,MM\(/V7TFTI ?)U;XJ?$U--U*XR[[6
M;P]\/_#OBVQMQLP2IU9FY_+^F<F^A]6E14\^SKEKW^'#89SBO^XF(J4)/Y4K
M'\PYQ],K(Z&+=')\KE/#<B:G7Q"BW)W]WDP]+$Q5M+MU%J]M+G#>'?\ @Y)^
M(\&HP'Q=^R[\/-1TLS1"Y3PQ\5O%FDZHD!<"5K;^V_ .H:=-,J$E5D>%">"P
M'(]+%?0]RUTG]1SO%1K6=O:82E*-^E^3$J27FHR?DSS*7TT,-&HO;Y11E!RB
MFH8FK&5FUS-<^%46TKM*4H)M6<E>Z_6/]EG_ (+0_L;?M+:II7A#4M>U?X&?
M$/6+F&PTOPO\75TO3-'US4[B6*"VTWPW\0M)O]2\$ZGJ-Y-.J6]G/=V>H3L<
M);D@BOPKC;Z//B%P;0GCX4:>9933BY3JX7FE*$4FW*I0G&->$8I-RG[.5-=9
MJZO^]<$_2!\.>-:T,%1Q,L%F52:A&GB>6$9S;@E&G7C*="<Y2G&,::J*I)W2
MA=-+];00>1_G_.:_"GH?MPM !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % '__T/[^* /B;]LOXD_M/:3X7MOAC^QO\-5\8?'/QS!/'%X^
M\4RV6C_"KX)^'L2Q3^-_%^M:N&M=8U^65&BT?1;.#4+F6<&YN+<VL)67]#\/
M\IX,K8]YOX@8MT.&\,TW0I)SQ.,GI:C2C'X(=:M:<J<5'W(3]I)6^)XWQ_%M
M/+GEO V'IU.(J\6HUJSMA\,O^?M5[SETITX*3<O>E'D34OQJ\$_\&^WBGXAZ
MWJ_Q"_:\_:O\0^)O'/B^[BUGQ<OPUT6WU35]3UJ96:[N=9^)?Q0M]:N?$$T0
M80PR1:#I\<$*"."**$)$G]"9A]*C"91AJ64\ Y'1H99ADXTOK$Y1C&'10P^&
M=-4[_%).O5<I/FG.4FY/^><+]%VKG^)JYOXB9S6Q.9XJG!U8X>$'^]2?-*5?
M$1J.KRW4:;6'HJ"3Y81BU"/VKX=_X(.?\$^]$M8;?4O#7Q;\6RQHJO=Z[\:O
M'-A),P W.UKX0OO#&G(6/9(E4>G3'YUBOI-^*V(J.=+$8&@F]H8+#R2^=6%2
M7WM_Y?HV"^CAX583#QP\L)BJJBK7GB\2F_\ P"I!:^21K:K_ ,$+/^"=^H0O
M%9_#WXD:$[K@7&D_'+XJO+&3_$L6L>)M7M'(/.'C8?AUPH_26\6J<N:IC,)4
M\I8'"?G&E!_<_P#@]$_H[^%#@X4\!7@GVQF+_P#;JTOR/CGXL?\ !N3\(M2M
MM0N/@E^T#\0/"%]-N:WT7XH>'/#'Q'\-S(6#-87=UH5KX%\326LF,$S7-V!Q
MN1P,']!R/Z7'$5"<(<1Y7A,326\\/4JX>I?^9*;K4D_\-./DUN?G.;_1(X2G
MS5N&\PQ>$Q3J*25:-/$0:NGR2:C1K2C=:*5:5FE=22Y3WG]B9/V^/V$?$>C?
ML]_M::'<_&S]F;5KY-"^&W[17@36]2^(#?![4KBZ%OHWA_XB6VI6=E\0-*^%
MNKO+'#;W=[:WMOX6G94EU!M+8'3_ );Q&GX7>)>$J<5\#5%EG&%.//B,!6IQ
MH+%Q4;SJ8>4)2H2Q,+-RA&5-XI*\**KJU;[#P[H^)GAU6APOQM&6:<*SJ..'
MQ]*I.O4P\IU&H4\1"<57CAVG%1F_;+"_#4K/#I3I?N@#FOYL/Z$"@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * /__1_OXH ^7OBW^VM^R1
M\";HV'Q<_:*^$'@?5T#DZ#J_CC17\28CX?9X;T^YOM==E)Q@6^><<U]ED/AY
MQSQ/#VN093F&*H=9TZ$W37K4:4%\W\SY7.N.>#>')^RSW-,!A*SBVH5:].,V
MENU!RYFM5LGNO(^0]1_X+:?\$WM/NYK2/XZZOJGDN8VNM$^#WQEU6P8^L5]:
M^!7MYUP>J,0?6OOZ7T<?&"M351Y7"G=7M/%X.$OG&6(4E\TO\_SV?TB?!^-6
M=*&;.HX.S=/#8NI"_E.%!PEZQ;7ST.\\%_\ !73_ ()S^.7BAT_]J3P)H%Q+
M)Y0@^(-GXG^&C*^=NUY?'FA:!:H=W<R ?AU\O,? ?Q;RR[K9'BZJ2O?#^SQ*
M_P#*$ZGZ_P"7JY1XY>$V=P<\'GF"ARMIJNY89IIV=XXB-)K;=JW;2U_OGPGX
MV\'>/='@\0>!_%?AOQCH-TJ/;:WX5US3/$.DSHZ[T:+4=)NKRT=67D?/7Y=C
M<OQV75WA<PHU:&)B]85(2A)>L9)-'Z?A<9A,=16(P56G6P\E=2A)2BT^J<6T
M_O?^?45QG0(0#U&>WX>G;@T[L Z#Z#I]/SI ?@G^V%_P7&TK]DO]I#XG?L]W
M/[-^I>.)OAQ>>&K1_%<'Q2T[P]!JQ\1>"O#?C%771[GP?J4MF+1/$(@.9Y Y
MB+Y ;:O]/^'_ -&O&<><(8+BNEF]+#0QD:C5)X:<W'V=:I1^-32=W3YME:]M
M;:_S#X@?2;RC@#B_&<(XK*Z^(KX.5*+J1KTH1E[6A2KJT9JZLJJB]U=/4^I_
M^"</_!37PW_P4&D^*^FVWPRNOA3X@^&*^$=071[SQA;>+V\0>'?%G]MVD6LP
M7-MH6A)9FPUKP]<6TL.V4@&*0L/,"CXCQ<\&\=X4_4:E7&1QV&QOM8\\:3I<
ME2ER-P:<I-WA4A)2NMY*WNW?W?A'XQ9=XLT,;4PF$J8.IA)4WRSJ1J<].ISI
M34H)15JE.I!Q3DTE&3:YK+[Q^.?Q<\._ 3X-_%#XT^+%>3P]\+O OB;QSJEM
M%((I[Z#P[I5SJ*Z;:R%) MYJ<\*6\/RM^]E7@]#^8\-Y'B^)L_P7#V M]<QN
M*IT8-[)U)J/,_*-^9^29^FY]G&%X>R3%Y[C;_5,'AZE::6[C3BY-+S=K+S:/
MYS)/^#E'2X+>8S?L>ZLMW;6DTUQ;)\;](D6.>VMWFN(!,/A_O=$>-E#[,L!G
M;VK^MX_0]Q<YIPS^C[*4DD_JE173:2=O:VZK2]NE^_\ (R^F-E',Z,LCQ"Q<
M4^:*Q5%I2BFY*_+S-*SUY.9I74+^Z?TJ_#CQ>/B!\/? GCP6!TH>-O!OA?Q<
M-+-R+TZ:/$FAV&M?8#>""V%T;/[;Y?F"-/,V[MJYP/X]S3!?V;F6(R[FYW0K
MU*?-:W-R3E&]KNU[7MTO\W_8V"Q/US!T<7;E]K2C.V]N:*E:_6U['9UP'2-=
MMJ,V,[59L>N!G'XXIK5V!Z*Y^)7[%_\ P61L_P!K[]IO3_V<8/V>[_P#)>Z9
M\1M1;QA<?$JR\10QGX?A?,ACT2#PAIDTG]ILV S7">2.S]OZ)\0O "OP#P8^
M,*F:T\5#GP\526'E3?[]-IN;J27NVV2=_+K^!< ^.V%X\XSJ\'T,MK8:=&.(
M;JRK0G%O#SC!J,(QYM6[WDXVTY5--N/[;U_.I^^A0 4 % !0 4 (3@$^@)_*
MFM78#\._B]_P6<MOA1^VMJ/['3_L[7VNW%E\9OAC\)(_B#'\3['3[69?B,?A
MP/\ A('\-R>#KB[A_L4_$  VJW4GVC[,,2IYI\O^C\@^CW5SWPXCXA1S:%*G
M++L5BG0>'E*2^K/$_N_:*JHOVGU?XFER\WPOE7-_/6?>/='(O$C_ (AU/*JE
M2O+'8:A&NL1!0Y<0L->I*#I\Z=-XBW)%34K0?M(\T_9Y/[;'_!;;2/V-_P!H
MSQU^S]>?L]W7CR?P5IWA/43XGA^*VD^&5U%?%/AJQ\0K$-%N_">I7%N]D+SR
MCB:7S-H;"[@*Z/#CZ..,\0N$\-Q51S6&&AB*E6/LWAIU.7V<W"_/&:3O:^J5
MMM;7./Q)^D7EWAQQ16X9Q665L54HT:=3VD*]*":J1YK*,TI-JVT>9[:*\>;]
MTK.X^UVEM=;/+^T6\$^S=NV>=$DNW=A<[=^,XYK^:9QY9N/9M'](1?-%2[HL
MU(PH * /_]+^\'XE>!-'^*'P]\;?#?Q#?:YIV@>//"VN>$-;O?#.M7?ASQ!;
MZ3XAT^?2]1?1O$&GLE_HNI&TN7$5U R30.0\;*X!'HY3F5?)\TP^;86-.>*P
MU:%6"J0C4IN5.2E'GIR3C.-TKQDG&2TDFG9\F/P=+,,%5P%=SC0K4Y0DXR<9
M*,E9\LEK%V>C5FGJFGJ?FCH'_!$7_@FSX>B>.'X$:I?O(NV>?5?BW\7[A[@G
MJ\RQ^-H+9Y"QSN" YK]CQ?TC_&'&-2J9K&*3TY<+A%;T_<W7WGXWAOHY>#N%
MDYTLI;<H\KOB<6TUVY77Y-+Z>[IT,/Q+_P $+O\ @G?KMO+!IGP[^(7@N64/
MB[\+?&GXFEX6;^..S\2>(/$>DN0>=KV[+[$<5T87Z2WBUAYJ5;&X7$)=*F#P
MNO\ V]"E3G]TK^:W>53Z.'A*Z$L/A\!B*,97^#&8MVOVYZTTM]K6_3\Y_CC_
M ,&YU[:6-UJ'[-/[1%W=W,-O.8/!WQJTBVM/MS(H:&WB^('P[LM/BL6D"E"]
MWX>O<D@DCG/ZWPU]+>,ZT:?&.40]FY*]7!R;Y>[]AB)3YN]H8BE_E^0\1_1#
MPT<+;@W-Z].K&ERJ&)LN>2M9NMAHTDFTFFYT*VK3MHT_Q \<_";]MS_@G!\2
M+:XU73_B?^SWXIN;Z.'1?&7@K6I],\+>-3:37301Z1XL\+SS>!O'PEBB=SIN
MI)/>B%BT]A&I('])Y;GOAGXQ9.X4IX/-<)&#<Z5:/-5HW4>9RI5?W^'LVDZM
M&4:?,K1K29_,V:9%XN^">;^W2Q>";G",:E&7+3K1A4J.G"-2FGAZ[DE)^RJP
ME6Y9ZX>-]/V>_8B_X.!-;LKO2O 7[;.D1:SHS+':Q_'7P/H?V;7=*$<,2"Z^
M(7P\T>)K;7K5GW//J/AZ&"XC')THH&E'\\^)7T5*+A4S3PXJ.%>]_J5:=X2N
MWI0Q$VG!I64:>(<D_P#H(<FHO^A/"[Z6]'$*.6>(T4E"FV\92@^9<D(7=;#T
M[^TYG[23J8:*:2UPL(KF?]2G@WQGX3^(GA70/''@7Q'HOB_P?XITRVUKPYXF
M\.:E::OH>MZ5>()+:_TS4K*6:VN[:53PRMP<@@$$#^)\PR_'95C:N6YE2J4,
M?0FX5*=2+A.$XNSC*,DG%KJF?V]@\9A,QPE/'8"K3K8*M!3A4A)2A.,E=2C)
M-IIK5--_Y]*>A^AKC.D_AQ_X* 65EJ'_  6P\266HVT5Y87?[1?[(UG?VLT:
MR176GWVG?L^6.HVLD; K)'=V%S+$P((*N:_TG\+JE2E]&VC4I2<:D<HS9IK2
MS4LQE%_*23]4?YM<?X;#8KZ55>GBH*=+^T\J=G_U[RU?DW\CVK]@*6?]B#_@
MLMXZ^ 5\\FF^%_&'C?XM? B"!+ATM)M%\33+\6_@??RVLACB+KH]EI]G&0"5
MGU.15)#'/S7BFH^)'T><)Q53]_&X;#83&-M>]ST_]CQJ4E=ZU'.HU=7C23>J
M5OM/"ZE#PY^D+C^%E!4<!BJV)PT8PJODY:EL=A&Z3Y8IJG[BM%RA*K*,92BV
MW^H?_!P%\>(_A[^R5X7^#EGJ"VFK_'WXA:=9ZK$+MH9E^'GPU6+QUXKN&MX@
M9[BRN=;M-'T^=<!&CO2K9SM/XQ]%KA>6;\>5L_G!RP^5824HZ73Q&(_<45=Z
M*2C*K5B][T[K:Z_7OI0<4TLEX"IY$IPCB<UQ48.+E)2>'H+V]>48P3G47NTZ
M4XJT6JMI/7EG_-_^V?\  F7X"_ #]A/1]6TO^SO&'Q"_9N^*WQG\9":T^R7R
MZI\3_'UCXCT?2[^-V:<3^&?"=S8Z>%<EE,3\#<0/ZW\..)X\4<7\48G#U.?+
M\+G&$PE&TN:+AAJ%2E*<6E:U6I&5333WEO:Y_+'B7PR^&.!N%<)B:<8YE7RS
M%XFJ_9NG)3Q-6E5Y)1DW-2IPG&G+F;=XNZCLO['/$?[7?P7_ &,?V)_@?\5/
MC/K=U:V,WPD^%^D>%_"^AVT6I>,?'/B(_#S2+U/#_A72);FTBN;I+*VDGN+B
MXFMK&QMD::YGBB4L/\_<OX$XA\0O$''Y%P[34JWUVO*I4F^6E1I^WE%U*L[-
MJ/,U&,8QE.<FH4XRFTG_ 'WG7&F1<!<$T<_S^HXX6GA*?+"-G4JR5+FY*<6X
MIR:BW>4HPBDY3E&*;7Y*W7_!Q#XBN'U+Q3X>_8@\5ZA\*-&U6'3M3\7WOQ(U
M2-[+<]NLD>J:KHOPIUSX=Z-JH^TKBUGUT89E4N-P)_>:?T3\)%4\#C.)</#/
MZM-RC1C0C[WQ6Y8SQ5/$SC[K]Z.'>SLM-?P"K]*C%SA7S3 <-8JKPUA\1"E/
M$.O)63<.:3<,+4PT''G^&6*6R4I0OI^PG[$W_!03X%_MV^#]=U7X9S:QX;\:
M>$HX/^$X^%WC%=/M_&'AN&^:Y@T_6(6TN\O](\0^&-2N+2:.#4+&>6)9HG@G
M6"X5XE_ /$;PMXF\,\PI8?.E3JX"O?V.)I.3HU&DG*'O1C.%2*E%RIU(J5FI
MQYH2C)_OGA_XE\-^)&63QV1RG#$4I.-6A5Y55IVE**D^24X2A)Q?+*,Y+1QE
MRSC*$?Y;?^"*W_*3K0O^Q;_:1_\ :-?VG](K_DRJ_P"OV7?^D3/XX^CQ_P G
MIQOIF?\ Z?IG[H?MH?\ !:SX/_LS?$G4_@?\+_ASXB_:&^+N@ZM#X=\2:?H.
MK)X>\(>'_%%P;7;X2_MN#2/$NO>*?%EL+E5N;+1M*O5M9C]GEE2Y5X5_FSP\
M^CKQ!QED\.)<YQE#*>'ZM-U*<ZD>>K.DN:]7D<J=.E2;B^6=>K3YE[\4X6;_
M *'\0?I"\.\&YM/AK*,+7S;B6%>%&5*FW3IQJU.2U/VG).=2:4XN4</2K.#]
MR?+.Z7CWP)_X+\_#7Q+\2;#X8?M-_ SQ5^S7?W^L6.B2^*[S7KC7_#/A>[U6
M.!M,E^(.E^)?"OP_\;^#M)N6N$5K]M,N;2W219[AH;8/,GT'$OT6\YPF3RSK
M@O,\/G5"-*4U3C!0JU%!M36'E2JXBA6DK-\BK1G*SA!2J6B_GN'OI09'6SU\
M/<;9=7R3&+$1I.I.HIT:7/352$\1[6&&K482;C#G="4$YPE*2@W./ZP_M>_M
MD?!O]BWX3O\ %;XL:C>W$.H7G]C>"_"/AQ+.\\5^/?$<EG/?Q:-X=MKN\L;!
M8X;&W>YN[ZZG@L;&T1I9I5&T-^&<!\ <0>(>>K(\BA%3C'GJU:EU2HT[J+G4
M:C*7Q-1C",93G-J,(ML_=>-.-\AX#R26>Y]4<<.G:$8V<ZD[.7+!-QC\*<I2
ME*,(13E*2BFS\0--_P"#BFZAU#3M<\6?L8>+-)^%>MZEJ-CH_BK2_B2;K5+]
M=-F>*\739/$'P^\+_#_7-4T]8V-U:VNOL;9P5D==K,/Z1K?1-C*E/"X#B+#5
M,_I0A*=&6'M&/,DUS>SKU<1",KKDG/#+G5FD[I/^<</]*M1=+,,SX>Q5#AJO
M5J0IXA5U)M4Y-7]^C2PTG9-SC#%3<+23ORS<?T4^.7_!6[X#?"[]EGX6_M9^
M!?#GB?XQ> /BC\0W^&MMI&BWFC^$_$_A7Q):>'?%6O:QIWBVQ\42P1Z7JFA/
MX5EMKFVW%R\L<L320NLC?DG#7@5Q3GG&N-X%S"K0P&;8+"?6'*:G4IU*;J4H
M0=*5)2YXS]M&496M9-.TDT?K?$OC7PIP_P &X3CBC&MB\GQF*]A%0Y:<X5%3
MK3FJBJN"@X>QFI*33O:U[J_U+^Q3^UAHO[:/P&TGX[Z!X+USP#INK^)?&GAJ
M/PYXAU/2=6U2WF\%>(KWPY=74MYHC2:<T5]<6321*C,5C(W8;('Q7B'P1B?#
MWB:IPQB\12Q5>E1HU'4IQG&#5:E&JDE-1E>*DD[Q6NVEF_M>".+<)QQPY1XD
MP5*I1P]:52*A-IRBZ<Y4Y)N+<?BB_A<D]U)JS/AGQ1_P60\!>&OVSIOV,9O@
M5X^N_$2?&_PW\$!XZ@\5^"XO#S:CXDN/#\,7B :7<72:Y_9UE%X@1Y8O*,Q\
MIE0,2N?TG ^ &;8WP[7B+',L)'!?V=5Q?L73K.IRTG43AS*#AS2=-I/FMJFV
ME>WYWF7CGD>6<?P\/:F"Q4\SJ8VEAE4C*BJ?-54'S6E4C-QA"HIRY8O2\8\T
M_=7X"?M@\_\ !;?7/^SROV:/TD_9J'M7]2^'^GT;(?\ 9/9E_P"],_E[Q!_Y
M2:H_]C? ?GE1^T/[=/\ P41_9,_9Y_:E\1_!SXI?L1:+\9_'4>F_#R]O_B+<
M:)\'[N;5HO&5A#%HUM<S^+["77IFT>!%MSO9T6)%V87A?YU\-?";CGBW@RGQ
M%DG$,LORQ3KQ5#GQ:Y71]Z;2I>XN:]^C;;W>I_17B+XK\$<(<6/A_.LF>-S6
MI"@_:*&'?-[9\E.+=5J3]Y./512O)QC9OUK]LW_@L=\/?V+?CK=_ ;Q!\#/'
M'C2^L?"7@CQ0OB/0/%G@K1-&%KXS75%M+$VNNW-M=PR::-(?S7P8MA# \$#Q
M/#SP SGQ%X:7$V"S'"X>E+$5J7LZE.O.=Z*@Y2O3A)-2YU9;WTMJK^IXB>.W
M#_AOG<<BS3"8BK7E1IU%*$Z,(VJ.2A%NK.FDVX2UORQ2YIN,;-_,_P </^#@
MKPOX+\0O<?!S]F3QK\4/A%!KMQX>M?C+XJU_5_AQX3\;:E8EDU"W^'TR> /%
M5AJODR6MPL2WEY974ODEOLZQ_-7V?#/T5\=F6%Y.(,YPV!X@=)5'@Z<(8BM1
MC+X7B%[>G*G?FBVX0J12E;FYM'\+Q9]*3+LDJ1Q619/BL?PVZKI+&SE.A1K5
M(\W-#"R]A5C6:Y)_%.E=QM'F5VOU3_8;_;V^#7[>/P_UGQ;\-(]9\.>)O!U[
M8Z9\0/ASXI^P'Q)X3NM5AGN-&O?M6E75[I.N>'->AM)S8ZA:RF.5[>:&1(;F
M":"/\2\2?##B+PQS6G@,Z]G5PF(BY4,12YO9U5%I3C:<8SA4IMI5*<DFN:,E
MS0G"<OVOP[\2^&O$O*IYCD,VJ]%I5J$W!U:7-S<CER2G%PJ*,G3G&34K26DX
MSC'[?K\X/T(__]/^X3]I[X83_&G]G3XY_"6SFN+;4/B+\)_'W@_2[JUE:&YM
M=6USPUJ-EI-S!*A#QRP:E)$RL""I&17TG!^<QX=XKRW/9J,J>#QU"M*,E=2C
M3J1E)-=4XIIG@\4Y0\_X:S#(XSE3EC,%6HJ2M>+J4Y04E>ZNFTU=-::I['^?
M-\.?VU/VP/@7JJ2> _V@?C;X+O;)1!>Z!<^.?$.NZ1;7T+*M_IU_X.^(,WBS
MPP)M-U""2WD1K ,CQLI(.0/]6,U\,_#SB?#6S'*LLQ%*3O&I&C3IR<7\,HUL
M-[&HU*+4D_:---.VQ_DUA_&+Q,X/S9T\-F>8PE2@X.$ZM64>9VYN:EB_;QYJ
M<XRA\$9)J46]T?M[^R=_P<-^-]+O].\+_M>> =-\8Z'--#;2?%#X5Z:GA_Q=
MIL<C6\37NO?#NZO;G0O$\,99Y)GTB[L+L@;8-/F;"G^;>._HFX&=*>.X"Q4Z
M&(2;^K8J7/2E:[M#$1BI4V]$E5A."U<Z\5M_3'AW]+[ZU7AE_'>&@U*48JOA
MX\DU?D5YT)3E&HN9S;=*HJEK1AAIM7?]/?P8^.'PH_:&\ :+\4/@SXYT+X@>
M!]>1_L6MZ%<F18;F+ N]*U:PG2'4M"US3W.RZL+V&"\MI 5DC4C _C#B'AO/
M.%,UJY)Q#AJN%S.B_>A-6T>THM7C.$EK&<&X25G%M-']IY!Q!DO%&54<\R#$
MT\5E=>"E"I!Z-/HT[2C);2A)1E%W4HIII=!\0_AQX"^+/A#6_ 'Q,\'^'?'?
M@KQ':266M^&/%.DVFLZ-J-NZD?O[*]CDC$T1.Z*5-LL+@.C*P!'+E6;9GD>/
MIYID]>MALQHRYH5*4W"<6NJDK/U6J:T::T?7F&78#-L'4R[-*-+$8&K&TZ=2
M*G"2[.+NG_7R_CK_ ."H_P#P1SUC]E^RU?X]?LZC7/%WP"M6EO\ Q=X<OKBZ
MUGQC\&H"Y<ZA=ZC*9=0\5_#6W+ -J4Q?4M&7!OGN;7?>6O\ H#X)?2$H\8U:
M?"W%_LJ'$TK1I5(I0I8M_P JBK1I8A]*<4J=?:E&G5Y:=7_/CQW^C8^',-/B
M[@=5:F4TVY5J;;G4P\=^;F=YU*,?^?DFZE%:U'.DN>C\W_\ !,G_ (*:>._V
M'_']OX4\776L>)_V=/%6L9\>^!T\V^N_"][>2A+SXA^ +,Y-MXELS^]U+3HM
ML6OP*WR_V@(I)?K_ !H\%\L\1\K>999&G1XLHT_W-71*K%+2A7>EZ;VI5'K0
M=DW["ZA\?X#^/&9\!YK'AWB.<ZG#M2IRSC*[E3DW9U*?55$]:D$K5U=I?6-:
MW]VOA'Q=X8\?^%/#WC?P7KNF>)_"/BW1=.\1>&O$6C74=[I6MZ'J]I%>Z9J>
MGW43-'/:WEI,KHP/0\X.17^9..P.,RS&U<NS&E.CCZ%25.I3FG&<)P;4HRB]
M4XM--=S_ $[P>,PF8X2EC\!4A6P5:G&=.<&I0G"24HRC):.,DTTUNF?Q/?MY
M_P#*;K7/^SD_V/?_ $1^SK7^C/AE_P HU4_^Q-F__O1/\Z..O^4K,1_V,LJ_
M](RP^H?^"\W@#6/@9^UQ\ /VOO!UHT-WXATG1-0-RD6V'_A9_P"SIXHL/%GA
MY)+F-=T-UXC\-:A!"222T&EL!D*0?B/HPYG0XFX$S;P_Q\O<ISFK7U^K9A2E
M1J.W54JD>9?WJOFF?H7TF,MGPYQMDOB%A81<O<;<H7BJ^ JK$4KS2O!U*<IJ
M[V5/W;V:EY]^W9XYT_\ X*5_\%-?V</@7X*U"/5_APNC?"GP8[6=VYM1IGCG
M3;3XX_'2^BN+7?,TMK\/8+;3G9=HCO+!HR00<>IX89=7\'_!C..*LQ@Z><N>
M)K*ZU4J,G@L"FI62_P!IE.IK=N$D[/KP>*&/H>+'C/D_!F JJIE$(X>$TJOL
MTXU8K&XQPG!.I*2PL*<$HN"YKIR6LETO_!QK:VUC\:OV=[&SACMK.S_9X^(%
MI:6T*".*WM;?Q?ID-M!$@X2.&%%4#L!7']$6<JF19O.;;F\UPS;[MTJMW\V=
M7TMXQCF.41BK16 Q27IST3Y7_P""QWQ \1ZMXT_96\&7-Q(OA_X<?L)?!C7?
M#EBP_<)K'CC0]>U;Q!J:HV4>2Z;X>:3"QQ]VTVG(.*^V^CIE6#H97G68QC_M
M6,XFQ-.I+^Y0E2A"/R^M5GZR\CX[Z2V.Q>+S_(\IJ3_V"CDU&<8V5U.JJU24
M[N_7!T$E:WNR33OI_8U^SW\'OAUX)_9?^%7P<T;PQH[?#VS^$OA;PU=>'Y[2
M*ZTS6[#4_#-DFN2ZQ;S!X]4N/$4UY//>R3!WN9IW=RS,37^?_%&?YMFO%^-X
MAQ5:I_:U3&U*OM$[2C)5&X\C5N50LE!1LHI)+1)']Y\.Y%E>4\,83A_!481R
MJC@Z=)4VKIPY$FI7OS.6KDW=R;;;;=W_ !U?\$R;^\^"O_!6CP;X"\$W-Q'X
M:NOBO^T#\"[ZT6:2==1\!6$/Q1BL+>ZED)FN/L=Q\,-%NA([,S26F\Y8DU_?
M_C+3AQ)X#5LVS-)XY8'+\:GHK5Y?5>9I+176+KQLE9*5DDDD?P1X.TO]5_I
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MQ.(KU(=I5)R7W.37]?=G2P6#HRYJ-*G"7>,8I_@E_7X]O7 =(4 % !0 4 %
B!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>mbrx-20210812_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="mbrx-20210812.xsd" xlink:type="simple"/>
    <context id="d20218K">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001659617</identifier>
        </entity>
        <period>
            <startDate>2021-08-12</startDate>
            <endDate>2021-08-12</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="d20218K">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="d20218K">0001659617</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="d20218K">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="d20218K">2021-08-12</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="d20218K">MOLECULIN BIOTECH, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="d20218K">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="d20218K">001-37758</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="d20218K">47-4671997</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="d20218K">5300 Memorial Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="d20218K">Houston</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="d20218K">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="d20218K">77007</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="d20218K">713</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="d20218K">300-5160</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="d20218K">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="d20218K">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="d20218K">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="d20218K">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany contextRef="d20218K">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="d20218K">true</dei:EntityExTransitionPeriod>
    <dei:Security12bTitle contextRef="d20218K">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="d20218K">MBRX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="d20218K">NASDAQ</dei:SecurityExchangeName>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140451476988680">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>Aug. 12, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity, Registrant Name</a></td>
<td class="text">MOLECULIN BIOTECH, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document, Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document, Period End Date</a></td>
<td class="text">Aug. 12,  2021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity, Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity, File Number</a></td>
<td class="text">001-37758<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity, Tax Identification Number</a></td>
<td class="text">47-4671997<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity, Address, Address Line One</a></td>
<td class="text">5300 Memorial Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity, Address, City or Town</a></td>
<td class="text">Houston<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity, Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity, Address, Postal Zip Code</a></td>
<td class="text">77007<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">713<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">300-5160<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity, Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity, Ex Transition Period</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MBRX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity, Central Index Key</a></td>
<td class="text">0001659617<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MV0+P?2FE.3W8DW'^QT;W/U!+ P04    "  W00Q3GZ ;\+$"  #B#   #0
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MOS^QO-9.&G_FB^$_7G\!4$L! A0#%     @ -T$,4P=!36*!    L0   !
M             ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    "  W
M00Q3"]TJ!>\    K @  $0              @ &O    9&]C4')O<',O8V]R
M92YX;6Q02P$"% ,4    "  W00Q3F5R<(Q &  "<)P  $P
M@ '- 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( #=!#%/%GWHS
M1P0  .00   8              " @0X(  !X;"]W;W)K<VAE971S+W-H965T
M,2YX;6Q02P$"% ,4    "  W00Q3GZ ;\+$"  #B#   #0
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:+GAM;%!+!08     "0 ) #X"  #L$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>96</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="mbrx-20210812.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mbrx.com/20210812/role/statement-document-and-entity-information</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="mbrx-20210812.htm">mbrx-20210812.htm</File>
    <File>ex_269919.htm</File>
    <File>mbrx-20210812.xsd</File>
    <File>mbrx-20210812_def.xml</File>
    <File>mbrx-20210812_lab.xml</File>
    <File>mbrx-20210812_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>mbrx20210730_8kimg001.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "mbrx-20210812.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "definitionLink": {
     "local": [
      "mbrx-20210812_def.xml"
     ]
    },
    "inline": {
     "local": [
      "mbrx-20210812.htm"
     ]
    },
    "labelLink": {
     "local": [
      "mbrx-20210812_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "mbrx-20210812_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "mbrx-20210812.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/sic/2021/sic-2021.xsd",
      "https://xbrl.sec.gov/currency/2021/currency-2021.xsd",
      "https://xbrl.sec.gov/exch/2021/exch-2021.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021_ref.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021_doc.xsd"
     ]
    }
   },
   "elementCount": 27,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 96,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "mbrx",
   "nsuri": "http://www.mbrx.com/20210812",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "mbrx-20210812.htm",
      "contextRef": "d20218K",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000 - Document - Document And Entity Information",
     "role": "http://www.mbrx.com/20210812/role/statement-document-and-entity-information",
     "shortName": "Document And Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "mbrx-20210812.htm",
      "contextRef": "d20218K",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.mbrx.com/20210812/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.mbrx.com/20210812/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Document Information [Line Items]"
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.mbrx.com/20210812/role/statement-document-and-entity-information"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.",
        "label": "Document Information [Table]"
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document, Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.mbrx.com/20210812/role/statement-document-and-entity-information"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document, Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.mbrx.com/20210812/role/statement-document-and-entity-information"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity, Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.mbrx.com/20210812/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity, Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.mbrx.com/20210812/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity, Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.mbrx.com/20210812/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity, Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.mbrx.com/20210812/role/statement-document-and-entity-information"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity, Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.mbrx.com/20210812/role/statement-document-and-entity-information"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.mbrx.com/20210812/role/statement-document-and-entity-information"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity, Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.mbrx.com/20210812/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity, Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.mbrx.com/20210812/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity, File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.mbrx.com/20210812/role/statement-document-and-entity-information"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity, Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.mbrx.com/20210812/role/statement-document-and-entity-information"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity, Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.mbrx.com/20210812/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity, Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.mbrx.com/20210812/role/statement-document-and-entity-information"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.mbrx.com/20210812/role/statement-document-and-entity-information"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.mbrx.com/20210812/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.mbrx.com/20210812/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.mbrx.com/20210812/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.mbrx.com/20210812/role/statement-document-and-entity-information"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.mbrx.com/20210812/role/statement-document-and-entity-information"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.mbrx.com/20210812/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.mbrx.com/20210812/role/statement-document-and-entity-information"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.mbrx.com/20210812/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r7": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001437749-21-019544-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001437749-21-019544-xbrl.zip
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M#IP$0E(104?GGVE=$C<@?09$SO68WRI7E6RP]H311E$>JPZ@6<9Q*EC,(P?
MR3:OKJ^VF)?"\E"4 "FL">+_3.-$=OKW>,_'K]^NKK]^L=A1VDWC QPEF[S-
MG9LNH#MP;4=Y(+Q^[= _\" @OFZQ@VV\_9"XT_;%)2PMOI.1V ;YS 8\[9U4
M((%[%CL+G JR)8MM?N&QR_]ZP\[?7?[/%ML<W&SP=*S\D ?]+8OQXC'F7<%"
M$/D^=P2<>[SHZ#O9G4QZ<',[4MQER$0[RI,*T>Q&*? "(!V)?!%(&" @$B3
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M+6MC8Z"OBB<6?'5XFAEY8&VD@?P+306?MD*CP!IBWA%)WZ+AS=T#6>#S/AJ
MK,,=;2+%W,?;T!WA23#:M"6%8Y(@ GB[ZKN*TC;L,:BP(U O\ X )DPQ&!>!
MU18"9N^I.U*5>""! L#8<85'EAUWG-1'/UQNW*"D 7,K86F(-S2J=@<M-/H)
MS5%R>11FU] ?3 H@&" 4OA=MV(< 3$(6Y-P],:<'_P"/^6B7@EE(01>BN#8Z
M"7&T>ZZYIPO<,7-:QKH'2Q8LQIQ&-(E4NNK6>"\[(D)=@4D7QI(="6+JR_%U
M=:?9W*NWFFMJUWT+02=!N)X/7+8GWT/0A32)_MQ67K/4MJ=8T5-]P1_KY-Y\
MPRZ-/YAB6,#,>_AGZBC @X[_2(]+_!?O?!6/#KZ"!F!)DC,ER6-#DL9PO$=L
M('>T3^)AT5<05L!;VS+0X@W-)AZ.A)G^SHXB?ER2X9J3X8"\#%WEWBE4XD#U
M3&07(Z=V!Q-:7(O%.IS_L MBB(I('=7.A=% 9$ZO3R"Q55)M1O68#^C&L65@
M.QZ/8Q;:5]='UPW8/F6R8#3+1D]#]?5K$@WPL5ZOKJFY9_8)>CNH<^2% HT=
M@SAGOI\&8OLZXD'L1#(DOG2N7!VV!T6Y:.+!P,:.0"XGZ5&4FR%HA0)O,%'"
M=C^#,G(\O%=$$481N9/(6[388 67@]R :_L8.17;O(:+8 G>]4#SU-'-PC@8
M,\(P%%BD8%PF0RL&JTHO-\\@R/&]&?94#/]&?8^,2=P.G1EX'BQ%4.D1^[0R
M7 W9>$-C-[8LYMCG?3!H.;%4"N;='P8SQF"@#H:%..LI'P-F*@4[ZQ90I<.F
M8+EZ'MQUCLYGIY\ ?A,52VW]LH]G'^P:L*J=W7VVV>N'8-]R#+.ECD1.KS?)
MS!U;9+$BW,=!@J*!P%X%&&@Q9ELD)F:M35KZV1BY>; LDFUTC*/%B S$B<A$
M G:!FV9Q&MW*6Y/8 7:O)SO&,6#1)40S#[H2\8-A8[;I*!42YFYYC!'0)(VT
MC&Q[2@$BTC#T,#P/[(['-$[&I61LTC0Z'O<S6S".E2,)A=K!2+1&0.B3=:VC
MX1Y^8K"\W-@%:=N6GJ$Z0[1.3S@W%'4L\@/<>:>#3E^R1$>CWQ7#(_ 884H!
M1BDX$('JXI/FB!%T"]X4IKT99!\C>>"CH<(40DDQCU!S<*,)('3B&^!9D=#4
MZLI8\#6-MAMHHB/)*$BPX?%.WQ30(/ L:5;!/O=].-+H.3^^/OY,I\=B;6X<
M)TD/46,4>HO=Z=AX+,2-UL \CX/61 R.YNND1)H%+T:%#3CFP-/1%OC\(VL%
M+ .51L"BVA%'$B3:*7*F][+30?_0&68A 5R($BXH6BW8J2=I7^_/+DZW1MT^
M9E%_9Q''22@V%H\NRX+3*>Q,.8#'-'+-:<C7JJ_"@G'&-HA(9$;L'!/@T $C
MV.;IN_.M>=(=II*2K'Z[<7'Z[M.(OLI(867Z<=L3G<1DFIHKE*Q*E[+,V'RL
M#]>7^6#%_%:3R,8*$XP\V^O8D;J[?Y$XXL7IEV_G@SU0FNGPGU\.>E$V\<71
MZ8G][O+DZ)-]].'ZY/(-,*P[WH_WC0;_!MVG8F@Q^ZPG]*[JX?=]IBT4]FN5
M_H'G1HV7[*=[ /CX?CP $(H_O/WKK\>?97 S$0"3DV_9/0*R&%U!;3>2G3'I
MR4,YQJ-;*7UFZ^DSFSHLF=E6'TB/9-^N@-=F)A5F_>!6WF,>' <5Q"0QL<VS
M+^^WQO-T4.\2Y.4<].($D^?@PB8JJB9:F=D0QD_<UPH4LG:=64P*EG$?\"%5
M9HRIEYEX?+OV3KL8*D^/ "\,U%E"-:EUZ&/+$N)Z_5C"9@.;S 30J]SQ(G+$
MG)W?EG\ROT,-$5:'LP&GW\.PD\AB:VG@]$B#&8,R39.%O&A#]5.H0$4-")2;
MTL.UYI1VA"8UV9^@>&N@#51OY(HFW5I'>;M +9@K&X#U7$C!9)AX252&N6$1
MFMS()9&(,M++\CS=H3"D)E&RUC"3-:/?$9\9F6/CC# T*YY"H662R60GW%G0
MH1Q?,-W>:U.6!.4Y&/IMY<G8WS[U^HZ*^R;5[RRWQFV3!J2MGE;NI*NV]JBR
MCS+;U]1=-TAM1N]! $-CB0)J^L,Y%]JE0Z< /1XQ4GT7X>GU,Q]*=PB\,&);
MP:G3*DPAF3OW,Q33(/),$$_PI^#,RE%&'I(P4E1L (NJV^]/C>,I#.%8DZ_%
MI$_0\O%&F[)%0G1- Z/2NZ$'R9]([B@\]YB-Y\B(/$JD7 '\M?9%XY'+D=+K
MME74!6T+MJ9=6W"S238PJ<MAVH;M] 3&!6'[$8@_A'<>[7?UDFD-^ -@4&IP
M#3PXO,M1TV-71Y=7]K'ZMUW'NB6)_KXD4E3'-.R<H$D=3(2YY=(C 5=(><!B
ME4(NBQ]Z(BF(WQ'VU29-,PTR;U%6R"(1*2"#:=4ZYBE,<HWH=&  A^[)<NF
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MG''/>_V4-F\_W!OMX2BJ:?%5+.&F/4TNMI]<:$_I]R#);K&?#;6PI(UD*W1
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MI:(Q\,^1\3[6&_W-Q]4?2Y^(_%Z[.X!>^_*B-_BQYG[YH=?_T,3)#RX 8\
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MCB402N/!B12?^<8X,&SL 6U>10)]JKIO$='>/;=&<I*T\)\7<A!<^6D]]2[
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MW]I1XNF@=^W=9&3(X&K])25#$)\];CR1NW8^A_](X$2_S;+Q?U!+ P04
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M.)#E,9"?6*QD89@PGA9UX*T$%2W81BJX'AU(HT$JQ10KX(/\NL$JJD[4K$E
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MN$J]C$\K^LPV,A/,<'W@GQ;B<O8_ %!+ 0(4 Q0    ( #=!#%->KB^3BAX
M "8T 0 -              "  0    !E>%\R-CDY,3DN:'1M4$L! A0#%
M  @ -T$,4[M3<7I!#@  ;%D  !$              ( !M1X  &UB<G@M,C R
M,3 X,3(N:'1M4$L! A0#%     @ -T$,4U;BBAMR P  * X  !$
M     ( !)2T  &UB<G@M,C R,3 X,3(N>'-D4$L! A0#%     @ -T$,4R8L
M6CGQ!   9"X  !4              ( !QC   &UB<G@M,C R,3 X,3)?9&5F
M+GAM;%!+ 0(4 Q0    ( #=!#%.^]VUL'@8  &(^   5              "
M >HU  !M8G)X+3(P,C$P.#$R7VQA8BYX;6Q02P$"% ,4    "  W00Q3;%S!
M08P$   S+P  %0              @ $[/   ;6)R>"TR,#(Q,#@Q,E]P<F4N
M>&UL4$L! A0#%     @ -T$,4UL#3X/_#0  RPX  !D              ( !
M^D   &UB<G@R,#(Q,#<S,%\X:VEM9S P,2YJ<&=02P4&      < !P#) 0
&,$\

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
